XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments and Derivatives (Tables)
9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Effect of Derivative Instruments on Consolidated Statement of Operations

The tables below present the effect of the Company’s derivative financial instruments on the Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2024 and 2023 (dollars in thousands):

 

 

 

 

Net Loss Reclassified from AOCL into Interest Expense

 

 

 

Location of Loss Reclassified

 

Three months ended September 30,

 

Derivatives in Cash Flow Hedging Relationships

 

from AOCL into Income

 

2024

 

 

2023

 

Terminated interest rate swaps

 

Interest expense

 

$

(428

)

 

$

(279

)

 

 

 

 

Nine months ended September 30,

 

 

 

 

 

2024

 

 

2023

 

Terminated interest rate swaps

 

Interest expense

 

$

(1,448

)

 

$

(835

)

 

 

 

 

 

Loss Recognized in Earnings on Derivative

 

 

 

Location of Loss Recognized

 

Three months ended September 30,

 

Derivative Not Designated as Hedging Instrument

 

in Earnings on Derivative

 

2024

 

 

2023

 

Preferred stock embedded derivative

 

Other non-operating expense (income)

 

$

(18,257

)

 

$

(11,250

)

 

 

 

 

Nine months ended September 30,

 

 

 

 

 

2024

 

 

2023

 

Preferred stock embedded derivative

 

Other non-operating expense (income)

 

$

(14,451

)

 

$

(1,863

)